Report : Urinalysis Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Consumables and Instruments), Test Type (Pregnancy and Fertility Tests, Biochemical Urinalysis, and Sediment Urinalysis), Application (Disease Screening, and Pregnancy and Fertility), and End-User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, Research Laboratories, and Institutes), and Geography
Market for Sediment Urinalysis Test to Grow at Highest CAGR During 2021–2028
According to our new market research study on “Urinalysis Market to 2028 – Global Analysis and Forecast – by Product, Test Type, Application, and End User,” the market is expected to reach US$ 5,937.97 million by 2028 from US$ 4,065.79 million in 2021; it is expected to grow at a CAGR of 5.6 % from 2021 to 2028. The report highlights the factors governing the urinalysis market growth, including trends, drivers, and hindrances.
Based on product, the urinalysis market is segmented into consumables and instruments. The consumables segment is estimated to account for a larger market share in 2021, and it is further anticipated to register a higher CAGR during the forecast period.
The urinalysis market, based on test type, is segmented into pregnancy and fertility tests, biochemical urinalysis, and sediment urinalysis. The biochemical urinalysis segment is expected to hold the largest share of the market in 2021, and it is estimated to register the highest CAGR during 2021–2028.
The urinalysis market, by application, is segmented into disease screening and pregnancy, and fertility. The disease screening segment is expected to account for a larger market share in 2021. The urinalysis market for the disease screening segment is estimated to grow at a higher CAGR from 2021 to 2028.
Based on end user, the urinalysis market is segmented into hospitals and clinics, diagnostic laboratories, home care settings, and research laboratories and institutes. The hospitals and clinics segment would hold the largest share of the market in 2021, while the diagnostic laboratories segment is estimated to register the highest CAGR during the forecast period.
COVID-19 has presented the most significant global health emergency till date. Lockdowns resulting from the COVID-19 pandemic caused people to delay undergoing health checkups, thus affecting the number of tests being performed and sales of instruments, consumables, and reagents. The urinalysis market witnessed a shortfall at the beginning of the COVID-19 crisis due to disruption in supply chain and demand due to the lockdown announced by most European countries. However, a resurgence in testing numbers is seen as countries gradually ease restrictions on movement.
Abbott; ACON Laboratories, Inc.; ARKRAY, Inc; Beckman Coulter, Inc.; Bio-Rad Laboratories Inc.; Cardinal Health Inc.; F. Hoffmann-La Roche Ltd.; Quidel Corporation; Siemens Healthineers AG; and Sysmex Corporation are among the leading companies operating in the urinalysis market.